Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/36017
| Title: | Corrigendum to “Biological characterization of PM226, a chromenoisoxazole, as a selective CB<inf>2</inf> receptor agonist with neuroprotective profile” [Pharmacol. Res. (2016) 110(2016) (205–215)] (S1043661816302080) (10.1016/j.phrs.2016.03.021) | Authors: | Gómez-Cañas, M. Morales, P. García-Toscano, L. Navarrete, C. Muñoz, E. Jagerovic, N. Fernández-Ruiz, J. García Arencibia, Moisés Pazos, M. R. |
UNESCO Clasification: | 32 Ciencias médicas | Issue Date: | 2017 | Publisher: | 1043-6618 | Journal: | Pharmacological Research | Abstract: | © 2017 Elsevier LtdThe authors have realised that they failed to acknowledge the affiliation of author M. García-Arencibia to the “Grupo de Investigación en Medio Ambiente y Salud, Instituto Universitario de Investigaciones Biomédicas y Sanitarias, Universidad de Las Palmas de Gran Canaria, Spain” the affiliation had been mistakenly indicated as present address in the original article [1]. The Authors apologise for any inconvenience this may have caused. | URI: | http://hdl.handle.net/10553/36017 | ISSN: | 1043-6618 | DOI: | 10.1016/j.phrs.2017.04.002 | Source: | Pharmacological Research [ISSN 1043-6618], v. 120, p. 302 |
| Appears in Collections: | Artículos |
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.